Exchange: NASDAQ·Updated 02:59 PM EDT
CLLS logo

CLLSCellectis

$2.76
$0.14
(4.83%)
Today
EarningsAug 11
Mkt Cap$209.74M
Vol25,413.00

About

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
229

Frequently Asked Questions

What is Market Cap of Cellectis - ADR?
What is the 52-week high for Cellectis - ADR?
What is the 52-week low for Cellectis - ADR?
What is Cellectis - ADR stock price today?
What was Cellectis - ADR stock price yesterday?
What is the PE ratio of Cellectis - ADR?
What is the Price-to-Book ratio of Cellectis - ADR?
What is the 50-day moving average of Cellectis - ADR?
How many employees does Cellectis - ADR have?

Advertisement|Remove ads.